GPT and primary biliary cholangitis: On the other hand, in a single controlled clinical trial, use of CSA significantly reduced serum alkaline phosphatase, bilirubin, alanine aminotransferase, and gamma globulin in Primary Biliary Cirrhosis (PBC), patients with side effects tolerated well.